Abstract
Hypertension is a risk factor for the cardiovascular diseases. Although, several drugs are used to treat hypertension, the success of the antihypertensive therapy is limited. Resveratrol decreases blood pressure in animal models of hypertension. This study researched the mechanisms behind the effects of resveratrol on hypertension. Hypertension was induced by using the deoxycorticosterone acetate (DOCA)-induced (15 mg/kg twice per week, subcutaneously) salt-sensitive hypertension model of Wistar rats. Hypertension caused a decrease in endothelium-dependent relaxations of the isolated thoracic aorta. Resveratrol treatment (50 mg/l in drinking water) prevented DOCA salt-induced hypertension, but did not improve endothelial dysfunction. Plasma nitric oxide (NO), asymmetric dimethylarginine (ADMA), total antioxidant capacity (TAC) and hydrogen sulfide (H2S) levels were not changed by DOCA salt application. However, treatment of resveratrol significantly decreased ADMA and increased TAC and H2S levels. NO level in circulation was not significantly changed by resveratrol. DOCA salt application and resveratrol treatment also caused an alteration in the epigenetic modification of vessels. Staining pattern of histone 3 lysine 27 methylation (H3K27me3) in the aorta and renal artery sections was changed. These results show that preventive effect of resveratrol on DOCA salt-induced hypertension might due to its action on the production of some blood biomarkers and the epigenetic modification of vessels that would focus upon new aspect of hypertension prevention and treatment.
Similar content being viewed by others
References
Coffman TM (2011) Under pressure: the search for the essential mechanisms of hypertension. Nat Med 17(11):1402–1409
Tang EH, Vanhoutte PM (2010) Endothelial dysfunction: a strategic target in the treatment of hypertension? Pflugers Arch 459(6):995–1004
Schulz E, Gori T, Münzel T (2011) Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 34(6):665–673
Rush JW, Quadrilatero J, Levy AS, Ford RJ (2007) Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med 232(6):814–822
Bhatt SR, Lokhandwala MF, Banday AA (2011) Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur J Pharmacol 667(1–3):258–264
Rimbaud S, Ruiz M, Piquereau J, Mateo P, Fortin D, Veksler V et al (2011) Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS ONE 6(10):e26391
Petrovski G, Gurusamy N, Das DK (2011) Resveratrol in cardiovascular health and disease. Ann NY Acad Sci 1215:22–33
Cowley AW Jr, Nadeau JH, Baccarelli A, Berecek K, Fornage M, Gibbons GH et al (2012) Report of the national heart, lung, and blood institute working group on epigenetics and hypertension. Hypertension 59(5):899–905
Navarro-Gonzalvez J, Garcia-Benayas C, Arenas J (1998) Semiautomated measurement of nitrate in biological fluids. Clin Chem 44(3):679–681
Usanmaz SE, Demirel Yilmaz E (2008) A microplate based spectrophotometric method for the determination of the total antioxidant capacity of human plasma: modified cupric reducing ability assay. Fundam Clin Pharmacol 22(67–67 Suppl):2
Zhang H, Moochhala SM, Bhatia M (2008) Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis. J Immunol 181:4320–4331
Buluc M, Demirel-Yılmaz E (2002) Possible mechanism for depression of smooth muscle tone by resveratrol. In: Varro A, Vegh A (eds) Advances in Recent Cardiovascular Research. Monduzzi Editore, Bologna, pp 55–59
Buluc M, Demirel-Yilmaz E (2006) Resveratrol decreases calcium sensitivity of vascular smooth muscle and enhances cytosolic calcium increase in endothelium. Vascul Pharmacol 44(4):231–237
Buluc M, Ayaz M, Turan B, Demirel-Yilmaz E (2007) Resveratrol-induced depression of the mechanical and electrical activities of the rat heart is reversed by glyburide: evidence for possible K(ATP) channels activation. Arch Pharm Res 30(5):603–607
Lind L, Granstam SO, Millgård J (2000) Endothelium-dependent vasodilation in hypertension: a review. Blood Press 9(1):4–15
Soylemez S, Sepici A, Akar F (2009) Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats. Cardiovasc Drugs Ther 23(6):449–458
Montecucco F, Pende A, Quercioli A, Mach F (2011) Inflammation in the pathophysiology of essential hypertension. J Nephrol 24(1):23–34
Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM et al (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111(8):1201–1209
Martin C, Cameron J, McGrath B (2008) Mechanical and circulating biomarkers in isolated clinic hypertension. Clin Exp Pharmacol Physiol 35(4):402–408
Liu Z, Song Y, Zhang X, Liu Z, Zhang W, Mao W, Wang W, Cui W, Zhang X, Jia X, Li N, Han C, Liu C (2005) Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clin Exp Pharmacol Physiol 32(12):1049–1054
Chander V, Chopra K (2006) Possible role of nitric oxide in the protective effect of resveratrol in 5/6th nephrectomized rats. J Surg Res 133(2):129–135
Li J, Zhou Z, Jiang DJ, Li D, Tan B, Liu H et al (2007) Reduction of NO- and EDHF-mediated vasodilatation in hypertension: role of asymmetric dimethylarginine. Clin Exp Hypertens 29(7):489–501
Borde P, Mohan M, Kasture S (2011) Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats. Nat Prod Res 25(16):1549–1559
Castro MM, Rizzi E, Ceron CS, Guimaraes DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE (2012) Doxycycline ameliorates 2 K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. Nitric Oxide 26(3):162–168
Gómez-Guzmán M, Jiménez R, Sánchez M, Zarzuelo MJ, Galindo P, Quintela AM et al (2012) Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radic Biol Med 52(1):70–79
Mizutani K, Ikeda K, Nishikata T, Yamori Y (2000) Phytoestrogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Hypertens 18(12):1833–1840
Yan H, Du J, Tang C (2004) The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 313(1):22–27
Houtkooper RH, Pirinen E, Auwerx J (2012) Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13(4):225–238
Arrowsmith CH, Bountra C, Fish PV, Lee K, Schapira M (2012) Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 11(5):384–400
Wu LP, Wang X, Li L, Zhao Y, Lu S, Yu Y et al (2008) Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. Mol Cell Biol 28(10):3219–3235
Qian W, Miki D, Zhang H, Liu Y, Zhang X, Tang K et al (2012) A histone acetyltransferase regulates active DNA demethylation in Arabidopsis. Science 336(6087):1445–1448
Justin N, De Marco V, Aasland R, Gamblin SJ (2010) Reading, writing and editing methylated lysines on histone tails: new insights from recent structural studies. Curr Opin Struct Biol 20(6):730–738
Acknowledgments
This study was supported by a research Grants from the Novartis Research Award. We are grateful to Maggie Li for the editing of the English.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Han, S., Uludag, M.O., Usanmaz, S.E. et al. Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension. Mol Biol Rep 42, 35–42 (2015). https://doi.org/10.1007/s11033-014-3737-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-014-3737-x